Autopsy report · NCT02492074
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study
Cause of deathRegulatory or ethics
“No documents were ever submitted to the Ethics Committee or the competent authority because it was not possible to establish the planned PET measurements in Germany. Therefore, the study never started.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- Central Institute of Mental Health, Mannheim
- Sponsor type
- University, hospital or other
- Conditions
- Healthy Volunteers; Modeling Psychosis
- Interventions
- Delta-9-tetrahydrocannabinol; Cannabidiol; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.” - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
“there was no funding to begin the study” - Cannabinoids in Bipolar Affective Disorder
“study was never started and no patients were ever enrolled” - Needle-X: Usability Testing of a Smartphone Application
“The study was never started by the responsible party (medical student who is no longer at the institution).” - To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
“The investigators decided not to proceed with this study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.